ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

The Latest on X

About ASN

ASN / About /

Stuart Goldstein, MD, FASN

Stuart L Goldstein, MD, is Professor of Pediatrics and Director, Center for Acute Care Nephrology at Cincinnati Children's Hospital Medical Center. He received his medical degree from Columbia University and completed both clinical and research fellowships in pediatric nephrology at the Children's Hospital in Boston, Massachusetts. Dr Goldstein is Founder and Principal Investigator for the Prospective Pediatric Acute Kidney Injury Research Group, and has evaluated novel urinary AKI biomarkers in the pediatric critical care setting. He was one of two pediatric work group members for the KDIGO International AKI Guideline Work Group and has served on the KDOQI Hemodialysis Adequacy, Vascular Access and Pediatric Nutrition Guideline Work Groups. He has written over 400 journal articles, served as editor of two textbooks, and contributed book chapters to numerous texts including, Critical Care Nephrology, Evidence-Based Nephrology, Handbook of Dialysis Therapy, Management of Acute Kidney Problems, Pediatric Critical Care, Pediatric Nephrology, and Pediatric Nephrology in the ICU.

KHI Member support provided by: American Society of Pediatric Nephrology

Current Position/Titles:

Clark D West Endowed Chair,Professor of Pediatrics,Director, Center for Acute Care Nephrology, Co-Director, Heart Institute Research Core, Cincinnati Children's Hospital Medical Center,University of Cincinnati College of Medicine.

Degrees/Training:

B.A., Pitzer College, Claremont, CA 1986

M.D., Columbia University College of P&S, 1990

Pediatric Residency: Baylor College of Medicine 1990-1993

Pediatric Nephrology Fellowship: Children's Hospital, Boston 1994-1997

ASN Service:

Abstract Selection Committee Member, multiple years; Dialysis Advisory Group, 2004-2007; Acute Kidney Injury Advisory Group, 2008- 2014; Kidney Health Initiative, Board of Directors 2013 - 2018; AKINow! Steering Committee 2019 to present.

Leadership Positions:

American Society of Pediatric Nephrology Council 2012-2019 (Treasurer 2014-2019); Kidney Disease Outcomes Quality Initiative (KDOQI)/Kidney Disease Improving Global Outcomes (KDIGO)/Acute Disease Quality Initiative multiple work groups, with multiple chair roles in ADQI; North American Pediatric Renal Trials and Collaborative Studies, Board of Directors 2005-present (Secretary-Treasurer 2016 to present); Editorial Boards: Pediatric Nephrology, Clinical Journal of the American Society of Nephrology (past), American Journal of Kidney Diseases (past).

Honors:

International "Vicenza" Award in Critical Care Nephrology, 2013; Presidential Citation, Society for Critical Care Medicine, 2016; Michael Linshaw Memorial Lecture, The Massachusetts General Hospital, 2012; Boston, MA; Stanley Hellerstein Memorial Lecture, Children's Mercy Hospital and Clinics, 2018; David Cornfield Lecture, Children's Hospital of Philadelphia 2019.

Board Certification

Pediatric Nephrology

Research Interests:

Dr. Goldstein's research interests have focused on all aspects of acute kidney injury, especially in the areas of epidemiology, risk assessment, validation of novel AKI biomarkers and provision of acute renal replacement therapies. He developed and validated the pediatric modified RIFLE (pRIFLE) AKI criteria, is Founder and Principal Investigator for the Prospective Pediatric Acute Kidney Injury Research Group, a multi-national collaborative of over 50 pediatric institutions aimed at improving the care and outcomes for the child with, or at-risk for AKI. The ppAKI performed the largest prospective epidemiological study of pediatric AKI, AWARE, published in 2017.

Personal Statement:

I have been an active member of ASN since 2001 and served the Society in numerous capacities. Although my focus is on pediatric nephrology and the patients we serve, I have worked with my internal medicine nephrologist colleagues to advance care and advocate for all patients with kidney disease. My tenure as an inaugural KHI Board Member allowed me to see firsthand the impact the ASN has on transforming outcomes for patients with kidney disease. I am seeking this Council position to bring my unique perspective to the Society, given my experience at the intersections of the ASN mission.